Suchergebnisse - "Cottin, Vincent"

PubPharm (19)

1

Healthcare resource use and associated costs in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis

enthalten in: Respiratory medicine and research | 2023

von Cottin, V. | Spagnolo, P. | Bonniaud, P. | +5

2

Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis : The ISABELA 1 and 2 Randomized Clinical Trials

enthalten in: JAMA | 2023

von Maher, T. | Ford, P. | Brown, K. | +125

CommentIn: JAMA. 2023 May 9;329(18):1554-1555. - PMID 37159046

3

Pirfenidone in Unclassifiable Interstitial Lung Disease : A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use

enthalten in: Advances in therapy | 2022

von Kreuter, M. | Maher, T. | Corte, T. | +5

4

Post hoc Analysis of Clinical Outcomes in Placebo- and Pirfenidone-Treated Patients with IPF Stratified by BMI and Weight Loss

enthalten in: Respiration; international review of thoracic diseases | 2022

von Jouneau, S. | Crestani, B. | Thibault, R. | +6

5

Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort

enthalten in: Advances in therapy | 2022

von Cottin, V. | Guéguen, S. | Nunes, H. | +35

6

Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation

enthalten in: The European respiratory journal | 2021

von Justet, A. | Klay, D. | Porcher, R. | +29

7

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease : a double-blind, randomised, placebo-controlled, phase 2 trial

enthalten in: The Lancet. Respiratory medicine | 2020

von Maher, T. | Corte, T. | Fischer, A. | +8

CommentIn: Lancet Respir Med. 2020 Feb;8(2):126-127. - PMID 31578170

8

Fibrosing interstitial lung diseases : knowns and unknowns

enthalten in: European respiratory review : an official journal of the European Respiratory Society | 2019

von Cottin, V. | Wollin, L. | Fischer, A. | +3

9

A 2-Year Observational Study in Patients Suffering from Idiopathic Pulmonary Fibrosis and Treated with Pirfenidone : A French Ancillary Study of PASSPORT

enthalten in: Respiration; international review of thoracic diseases | 2019

von Jouneau, S. | Gamez, A. | Traclet, J. | +10

CommentIn: Respiration. 2019;98(1):16-18. - PMID 30947205

10

Health economic evaluation in idiopathic pulmonary fibrosis in France

enthalten in: Current medical research and opinion | 2018

von Porte, F. | Cottin, V. | Catella, L. | +3